Warning letter
Clean Solutions LLC: warning letter of Sep 6, 2024
FDA warning letter 686995 · Division of Pharmaceutical Quality Operations I
Key facts
| Reference number | 686995 |
|---|---|
| Company | Clean Solutions LLC |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Sep 6, 2024 |
| Posted date | Oct 1, 2024 |
| Issuing office | Division of Pharmaceutical Quality Operations I |
| Product type | Drugs |
| CFR sections cited | 211.34, 211.22(d), 211.67(a), 211.84(d)(1), 211.100(a), 211.165(a), 211.180(e), 211.166(a), 211.188(b), 211.22 |
| Inspection city | Clifton |
| Inspection ZIP | 07011 |
| Inspection start date | May 6, 2024 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: